Immune Checkpoint Inhibitors for Urothelial Cancer: An Update on New Therapies.
Ontology highlight
ABSTRACT: Ongoing trials are evaluating immune checkpoint inhibitors-used alone, in combination with cytotoxic, targeted, radiation therapies, or with other such inhibitors-for therapy in patients with advanced bladder cancer.
SUBMITTER: El-Mouallem N
PROVIDER: S-EPMC6248150 | biostudies-literature | 2018 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA